Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Veterans Affairs Extension for Community Health Outcomes (VA-ECHO).
Ann Am Thorac Soc. 2022 Dec;19(12):1951-1964. doi: 10.1513/AnnalsATS.202203-270CME.
The pulse oximeter is a ubiquitous clinical tool used to estimate blood oxygen concentrations. However, decreased accuracy of pulse oximetry in patients with dark skin tones has been demonstrated since as early as 1985. Most commonly, pulse oximeters may overestimate the true oxygen saturation in individuals with dark skin tones, leading to higher rates of occult hypoxemia (i.e., clinically unrecognized low blood oxygen saturation). Overestimation of oxygen saturation in patients with dark skin tones has serious clinical implications, as these patients may receive insufficiently rigorous medical care when pulse oximeter measurements suggest that their oxygen saturation is higher than the true value. Recent studies have linked pulse oximeter inaccuracy to worse clinical outcomes, suggesting that pulse oximeter inaccuracy contributes to known racial health disparities. The magnitude of device inaccuracy varies by pulse oximeter manufacturer, sensor type, and arterial oxygen saturation. The underlying reasons for decreased pulse oximeter accuracy for individuals with dark skin tones may be related to failure to control for increased absorption of red light by melanin during device development and insufficient inclusion of individuals with dark skin tones during device calibration. Inadequate regulatory standards for device approval may also play a role in decreased accuracy. Awareness of potential pulse oximeter limitations is an important step for providers and may encourage the consideration of additional clinical information for management decisions. Ultimately, stricter regulatory requirements for oximeter approval and increased manufacturer transparency regarding device performance are required to mitigate this racial bias.
脉搏血氧仪是一种无处不在的临床工具,用于估计血液中的氧浓度。然而,早在 1985 年就已经证明,在肤色较深的患者中,脉搏血氧仪的准确性会降低。最常见的情况是,脉搏血氧仪可能会高估肤色较深个体的实际氧饱和度,导致隐匿性低氧血症(即临床未识别的低血氧饱和度)的发生率更高。肤色较深患者的氧饱和度被高估会产生严重的临床影响,因为当脉搏血氧仪测量结果表明其氧饱和度高于真实值时,这些患者可能会接受不够严格的医疗护理。最近的研究将脉搏血氧仪的不准确性与更差的临床结果联系起来,表明脉搏血氧仪的不准确性导致了已知的种族健康差异。设备不准确性的大小因脉搏血氧仪制造商、传感器类型和动脉血氧饱和度而异。导致肤色较深个体的脉搏血氧仪准确性降低的潜在原因可能与在设备开发过程中未能控制黑色素对红光的增加吸收以及在设备校准过程中未能充分纳入肤色较深的个体有关。设备批准的监管标准不足也可能在准确性降低方面发挥作用。了解潜在的脉搏血氧仪局限性是提供者的重要一步,可能会鼓励考虑额外的临床信息来做出管理决策。最终,需要更严格的血氧仪批准监管要求和制造商对设备性能的更高透明度,以减轻这种种族偏见。